Editact Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 2

Editact Therapeutics General Information

Description

Manufacturer of biopharmaceutical products and biologics development services aims to advance precision medicine and healthcare innovation. The company's offerings feature proprietary biologic drug pipelines, GMP-compliant production capabilities, and integrated R&D workflows, helping hospitals, pharmaceutical developers, and research institutions access safe, effective biologics and therapies, enabling scalable delivery of advanced medical solutions across therapeutic areas.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hong Kong
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Manufacturing
Corporate Office
  • Hong Kong

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Editact Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 21-Jul-2025 Completed Generating Revenue
To view Editact Therapeutics’s complete valuation and funding history, request access »

Editact Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nan Fung Life Sciences Venture Capital Minority
Shanghai Healthcare Capital PE/Buyout Minority
To view Editact Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Editact Therapeutics FAQs

  • When was Editact Therapeutics founded?

    Editact Therapeutics was founded in 2023.

  • Where is Editact Therapeutics headquartered?

    Editact Therapeutics is headquartered in Hong Kong.

  • What industry is Editact Therapeutics in?

    Editact Therapeutics’s primary industry is Drug Discovery.

  • Is Editact Therapeutics a private or public company?

    Editact Therapeutics is a Private company.

  • What is Editact Therapeutics’s current revenue?

    The current revenue for Editact Therapeutics is .

  • Who are Editact Therapeutics’s investors?

    Nan Fung Life Sciences and Shanghai Healthcare Capital have invested in Editact Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process